POSTERS key to the improvement of clinical outcomes. Metastatic dissemination begins with adhesion of circulating tumor cells to the E-selectin-expressing endothelium with high levels of the main E-selectin ligand, sLeX, having been implicated in various carcinomas. Our study represents the first investigation of the sLeX involvement in HNSCC dissemination.
Method: A panel of stage-and anatomic site-specific primary and metastatic HNSCC cell lines was examined by flow cytometry to quantify cell-surface sLeX expression. Secreted sLeX expression was measured by Western-blot in serum-free conditioned medium. Quantitative real time PCR (qRT-PCR) was used to identify the fucosyl-transferases involved in sLeX neosynthesis in HNSCC. HNSCC invasive and migratory abilities were evaluated by Matrigel assays according with their sLeX expression levels.
Results: HNSCC originating from oral cavity (OC) expressed high sLeX that increased with advanced stage; it was highest in cells from recurrent (HNSCC14B) and metastatic (UMSCC103) tumors with known poor clinical outcomes. The expression of secreted sLeX was also high in OC supernatants. sLeX-positive tumor cells exhibited higher invasive potential than sLex-negative HNSCC.
Conclusion: Among various sites HNSCC, both cell-bound and soluble sLeX was predominantly expressed in OC carcinomas and associated with recurrent and metastatic tumors. The mechanism of sLeX involvement in OC progression is under investigation. A better understanding of the HNSCC dissemination will positively impact the clinical management.
Head and Neck Surgery Soluble VEGFR-2 Expression in Head and Neck Malignant tumors
Natalie Silver, MD (presenter); Yolanda Brill; Judit Baffi; Romulo Albuquerque; Jayarkrishna Ambati; Joseph Valentino Objective: 1) Define the spatial pattern of expression of soluble vascular endothelial growth factor receptor 2 (sVEGFR-2), a recently discovered receptor that has an important role in tumor lymphangiogenesis, in head and neck malignant tumors. 2) Examine the relationship between sVEGFR-2 expression and lymphatic vessel density in head and neck malignant tumors.
Method:
One hundred ten paraffin-embedded tissue samples from patients with malignant tumors were stained using immunohistochemistry for sVEGFR-2 and podoplanin, a marker for lymphatic vessels. Tissues studied included: squamous cell carcinoma of the larynx (61), oral cavity (16), oropharynx (20), hypopharynx (5), nasopharynx (1). Papillary (4), medullary (2), and follicular (1) thyroid cancers were also examined.
Results: sVEGFR-2 expression was identified in all squamous cell carcinomas of the head and neck. Expression was specific to the endothelial cells in blood vessels of both malignant tissue as well as adjacent normal tissues. sVEGFR-2 was not expressed in lymphatic vessels. This secreted protein was also expressed in tissue stroma. Decreased expression of sVEGFR-2 was correlated with increased lymphatic vessel density in tumors, as measured by podoplanin expression. sVEGFR-2 was minimally expressed in normal thyroid tissue but was abundant in the basement membrane of papillary thyroid cancer cells.
Conclusion:
We have provided the first evidence of sVEGFR-2 expression in head and neck malignant tumors. Its expression correlates with lymphatic vessel density in head and neck malignant tumors and ongoing studies will reveal the precise function of sVEGFR-2 in nodal metastasis and disease progression.
Head and Neck Surgery Supraglottic tumor Biopsy in a Patient with Spinal Stenosis
Jeffrey Bedrosian, MD (presenter); Jeffrey C. Liu, MD Objective: 1) To discuss the management of head and neck cancer in the setting of spinal stenosis. 2) To demonstrate a novel use of the GlideScope to facility direct laryngoscopy and biopsy in a patient with severe spinal stenosis.
Method:
In this case report, we present a 53 year-old woman with a 1.5-cm mass rising from the left aryepiglottic fold and severe narrowing of the C5-C6 spinal canal. Using a GlideScope to obtain indirect visualization, we successfully completed this procedure with the cervical spine in the neutral position.
Results: A survey of the anesthesia literature demonstrates the benefit of the GlideScope for visualization of the larynx while maintaining the cervical spine in the neutral position. This technique allowed successful direct laryngoscopy and biopsy in a patient with moderate to severe spinal stenosis.
Conclusion:
Our novel approach allowed reasonable visualization and biopsy of this supraglottic tumor while maintaining cervical spine stabilization.
Head and Neck Surgery Surgical Outcomes of Parotid Cancer: a 10-Year Experience
Won Shik Kim (presenter); Hyoung Shin Lee; Young Min Park; HyunJun Hong; Yoon Woo Koh; Se-Heon Kim; Eun Chang Choi, MD, PhD
Objective: The aim of the study was to investigate the treatment outcomes of malignant parotid tumors. This investigation is to report our experience with the management of patients with malignant parotid tumors that were treated with combinations of surgery, radiation, and chemotherapy.
Method: From January 1999 to December 2008, 126 patients with primary parotid cancer were treated. Data including age, sex, histologic findings, tumor stage, surgery type, complications, and prognosis were collected retrospectively from medical charts.
Results: Their mean age was 55.4 years (range, 15-96 years). Mean follow-up was 29.7 months. Thirty three patients were stage I, 40 stage II, 30 stage III, 23 stage IVA. Fifteen patients
